GAVISCON ANTACID LIQUID REGULAR STRENGTH

Company name

GlaxoSmithKline UK

E-mail address of the competent person responsible for the Safety Data Sheet

msds@gsk.com

Signal word

None

2.1 Classification of the substance or mixture

The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

EU Classification

Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary Not available.

2.2 Label elements

Label according to Regulation (EC) No. 1272/2008 as amended

Contains

GLYCERIN, MAGNESIUM CARBONATE HYDRATE, SODIUM ALGINATE

Hazard pictograms

None.

Signal word

None.

Hazard statements

The mixture does not meet the criteria for classification.

Prevention

Not available.

Response

Not available.

Storage

Not available.

Disposal

Not available.

Supplemental label elements

2.35 % of the mixture consists of component(s) of unknown acute oral toxicity. 11.57 % of the mixture consists of component(s) of unknown acute dermal toxicity. 21.01 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 21.01 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.

2.3 Other hazards

This mixture does not contain substances assessed to be vPvB / PBT according to Regulation (EC) No 1907/2006, Annex XIII. The product does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.